Relationship between Short Wavelength Perimetry and Central Corneal Thickness Values in Ocular Hypertensive Subjects

Abstract

Purpose

To evaluate the results of short wavelength perimetry (SWAP) of ocular hypertensive (OHT) patients and correlate these findings with central corneal thickness (CCT) measurements.

Methods

Thirty-seven OHT patients with a mean age of 50.2±8.2 (SD) years and 30 control subjects with a mean age of 50.3±8.5 (SD) years were included in this study. A questionnaire was applied to patients to evaluate the demographic risk factors that may predict glaucoma development. After a detailed ophthalmologic examination, achromatic and short wavelength perimetries and ultrasonic pachymetry were performed and the results were compared between the two groups with Student t test and Mann-Whitney U test. A p value <0.05 is considered as statistically significant.

Results

Mean CCT was higher in the OHT group (right eye; 558.13±28.39 μm and left eye; 558.94±27.30μm) when compared with the control subjects (524.66±30.53 μm and 525.86±30.46 μm, respectively) (p<0.01). A significant positive correlation was found between CCT measurements and intraocular pressure (r=0.5, p<0.001). Four right eyes (10.8%) and five left eyes (13.5%) of OHT patients had defects in SWAP. OHT patients with SWAP abnormalities had significantly lower CCT measurements in right (527.25±17.34 μm) and left eye (528.80±13.60 μm) when compared with OHT patients without SWAP defects (561.87±27.29 μm and 563.65±25.92 μm, respectively) (p<0.05). Significant correlations were found between CCT and SWAP MD, PSD, and CPSD (p<0.05).

Conclusions

OHT patients with SWAP abnormalities had significantly lower CCT measurements than those without. CCT is considered as a risk factor for the development of glaucomatous damage in OHT patients.

Keywords

Central corneal thickness Ocular hypertension SWAP

Get full access to this article

View all access options for this article.

References

Stamper

R.L.

, Lieberman

M.F.

, Drake

M.V.

Beckerμ Shaffer's Diagnosis and Therapy of the Glaucomas. 7th ed. St. Louis: Mosby, 1999; 299–304.

Coffey

, Reidy

, Wormald

Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 1993; 77: 17–21.

Mitchell

, Smith

, Attebo

Prevalence of open-angle glaucoma in Australia. Ophthalmology 1996; 103: 1661–9.

Hollows

F.C.

, Graham

P.A.

Intraocular pressure, glaucoma and glaucoma suspects in a defined population. Br J Ophthalmol 1966; 50: 570–86.

Leibowitz

H.M.

, Krueger

D.E.

, Maunder

L.R.

The Framingham Eye Study: monograph. Surv Ophthalmol 1980; 24: 335–610.

Gordon

M.O.

, Beiser

J.A.

, Brandt

J.D.

The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 714–20.

Kass

M.A.

, Heuer

D.K.

, Higginbotham

E.J.

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701–13.

Lundberg

, Wettnell

, Linner

Ocular hypertension. A prospective twenty-year follow-up study. Acta Ophthalmol 1987; 65: 105–8.

Schulzer

, Drance

S.M.

, Douglas

G.R.

A comparison of treated and untreated glaucoma suspects. Ophthalmology 1991; 98: 301–7.

10.

Goldmann

, Schmidt

Über Applanationstonometrie. Ophthalmologica 1957; 134: 221–42.

11.

Wolfs

R.C.

, Klaver

C.C.

, Vingerling

J.R.

Distribution of central corneal thickness and its association with intraocular pressure: The Rotterdam Study. Am J Ophthalmol 1997; 123: 767–72.

12.

Ventura

A.C.

, Bohnke

, Mojon

D.S.

Central corneal thickness measurements in patients with normal tension glaucoma, primary open angle glaucoma, Pseudoexfoliation glaucoma, or ocular hypertension. Br J Ophthalmol 2001; 85: 792–5.

13.

Argus

V.A.

Ocular hypertension and central corneal thickness. Ophthalmology 1995; 102: 1810–2.

14.

Brandt

J.D.

, Beiser

J.A.

, Kass

M.A.

Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 2001; 108: 1779–88.

15.

Herman

D.C.

, Hodge

D.O.

, Bourne

W.M.

Increased corneal thickness in patients with ocular hypertension. Arch Ophthalmol. 2001; 119: 334–6.

16.

Quigley

H.A.

, Green

W.R.

The histology of human glaucoma cupping and nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology 1979; 86: 1803–30.

17.

Sommer

, Katz

, Quigley

H.A.

Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol 1991; 109: 77–83.

18.

Heron

, Adams

A.J.

, Husted

Foveal and nonfoveal measures of short wavelength sensitive pathways in glaucoma and ocular hypertension. Ophthalmic Physiol Opt 1987; 7: 403–4.

19.

Heron

, Adams

A.J.

, Husted

Central visual fields for short-wavelength sensitive pathways in glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 1988; 29: 64–72.

20.

Johnson

C.A.

, Adams

A.J.

, Casson

E.J.

Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol 1993; 111: 645–50.

21.

Polo

, Larrosa

J.M.

, Pinilla

Predictive value of short-wavelength automated perimetry: a 3-year follow-up study. Ophthalmology 2002; 109: 761–5.

22.

Konstas

A.G.

, Mantziris

D.A.

, Stewart

W.C.

Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997; 115: 182–5.

23.

Johnson

C.A.

, Sample

P.A.

, Cioffi

G.A.

Structure and function evaluation (SAFE): I. Criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP). Am J Ophthalmol 2002; 134: 177–85.

24.

Ellis

J.D.

, Morris

A.D.

, MacEwen

C.J.

Should diabetes patients be screened for glaucoma? DARTS/MEMO Collaboration. Br J Ophthalmol 1999; 83: 369–72.

25.

Tielsch

J.M.

, Katz

, Quigley

H.A.

Diabetes, intraocular pressure, and POAG in the Baltimore Eye Survey. Ophthalmology 1995; 102: 48–53.

26.

Ellis

J.D.

, Evans

J.M.

, Ruta

D.A.

Glaucoma incidence in an unselected cohort of diabetes patients: Is diabetes mellitus a risk factor for glaucoma? DARTS/MEMO Collaboration. Br J Ophthalmol 2000; 84: 1218–24.

27.

Tielsch

J.M.

, Katz

, Somer

Hypertension, perfusion pressure, and primary open-angle glaucoma. Arch Ophthalmol 1995; 113: 216–21.

28.

Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal tension glaucoma. Am J Ophthalmol 2001; 131: 699–708.

29.

Demirel

, Johnson

C.A.

Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients. Am J Ophthalmol 2001; 131: 709–15.

30.

Spry

P.G.

, Johnson

C.A.

, Mansberger

S.L.

Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma 2005; 14: 11–9.

31.

Herndon

L.W.

, Weizer

J.S.

, Stinnett

S.S.

Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004; 122: 17–21.

32.

Hewitt

A.W.

, Cooper

R.L.

Relationship between corneal thickness and optic disc damage in glaucoma. Clin Exp Ophthalmol 2005; 33: 158–63.

33.

Jonas

J.B.

, Stroux

, Veiten

Central corneal thickness correlated with glaucoma damage and rate of progression. Invest Ophthalmol Vis Sci 2005; 46: 1269–74.

34.

Harper

C.L.

, Boulton

M.E.

, Bennett

Diurnal variations in human corneal thickness. Br J Ophthalmol 1996; 80: 1068–72.

35.

Lattimore

M.R.

Jr. , Kaupp

, Schallhorn

, Lewis

R I.V.

Orbscan pachymetry: implications of a repeated measures and diurnal variation analysis. Ophthalmology 1999; 106: 977–81.

36.

Wickham

, Edmunds

, Murdoch

I.E.

Central corneal thickness: will one measurement suffice?

Ophthalmology 2005; 112: 225–8.

37.

Shildkrot

, Liebmann

J.M.

, Fabijanczyk

Central corneal thickness measurement in clinical practice. J Glaucoma 2005; 14: 331–6.